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Cholesterol in A General Japanese Population: 
A Consideration of the Obesity Status
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Narumi Nagaic, Toshiyuki Yamadab, Naoki Sakanea
Abstract
Background: Limited studies have shown inconsistent data about 
the association between the uncoupling protein 1 (UCP1) gene A-
3826G polymorphism and high-density lipoprotein (HDL) choles-
terol levels. The present study investigated the association between 
the A-3826G polymorphism and low HDL-cholesterolemia in non-
obese and obese subjects.
Methods: Anthropometric and biochemical factors, in addition to 
genotyping by an allele-speciﬁ  c DNA assay, were measured in 294 
community-dwelling Japanese subjects (male/female: 127/167, 
mean age: 65 years). Obesity was deﬁ  ned as a body mass index 
(BMI) ≥ 25 kg/m2, and low HDL-cholesterolemia was deﬁ  ned as < 
1.04 mmol/L of HDL-cholesterol.
Results: The subjects with the G/G genotype (n = 27) showed a 
signiﬁ  cantly higher prevalence of low HDL-cholesterolemia (37%) 
than those with the A/A + A/G genotype (13%) in the obese group 
(n = 102). There was a non-signiﬁ  cant difference in the prevalence 
of low HDL-cholesterolemia between subjects with the G/G geno-
type (n = 45, 13%) and with the A/A + A/G genotype (15%) in the 
non-obese group (n = 192). A multivariate-adjusted logistic regres-
sion analysis of the presence of low HDL-cholesterolemia revealed 
that carrying the G/G genotype was an independent and signiﬁ  cant 
factor positively associated with low HDL-cholesterolemia [odds 
ratio (OR): 6.85, 95% conﬁ  dence interval (CI): 1.65-28.49] in the 
obese group, while carrying the G/G genotype exhibited a non-sig-
niﬁ  cant but reduced OR, by one-half, for low HDL-cholesterolemia 
(OR: 0.51, 95% CI: 0.13-1.96) in the non-obese group.
Conclusions: The obesity status could have opposing impacts on 
the relationship between the G/G genotype and low HDL-choles-
terolemia, providing insight into the need to consider the obesity 
levels when studying the association between the UCP-1 gene A-
3826G polymorphism and HDL-cholesterol.
Keywords: Obesity; Body mass index; HDL-C; Atherosclerotic 
risk
Introduction
Obesity is a global health problem due to its epidemic pro-
portions and the detrimental consequences associated with 
obesity [1, 2]. Uncoupling protein 1 (UCP1) is a mitochon-
drial component and a proton transporter, which uncouples 
oxidative metabolism from ATP synthesis, and dissipates en-
ergy through heat production [3, 4].  UCP1 plays important 
roles in energy homeostasis, and UCP1 gene polymorphisms 
have been implicated in the pathogenesis of obesity and re-
lated metabolic disorders, including lipid disorders [3, 4]. An 
A-3826G polymorphism within the promoter region of the 
UCP-1 gene is a candidate gene polymorphic site related to 
these disorders [5].
The blood levels of high-density lipoprotein (HDL) 
cholesterol (HDL-C) are a major atherosclerotic risk marker 
[6, 7]. The HDL-C concentrations are generally determined 
by the interplay of environmental and genetic factors [7]. 
Few human studies have directly focused on the relationship 
between the UCP-1 gene A-3826G polymorphism and 
HDL-C levels, but inconsistent data on this relationship 
have been reported in several cross-sectional association 
studies [8-15]. Although carrying the G allele or G/G 
genotype was reportedly associated with lower HDL-C 
levels [9, 11, 13], we found no association between the 
A-3826G polymorphism and HDL-C levels [8, 10, 12, 
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14] as well as a possibly protective association of the G/G 
genotype with low HDL-cholesterolemia [15]. The UCP-1 
expression is regulated by the condition of the individual, 
including the extent of obesity, and carrying the G allele is 
related to a reduced UCP-1 expression in obese subjects [9]. 
Therefore, the inconsistencies reported between studies on 
the association between the A-3826G polymorphism and 
HDL-C levels [8-15] may be, at least in part, explained by 
the difference in the studied populations, such as differences 
in the composition of obese and non-obese subjects. In fact, 
we noted that all of the studies showing that carrying the 
G allele or G/G genotype was signiﬁ  cantly associated with 
lower HDL-C levels were in obese populations {i.e., 42-47 
kg/m2 [9], 33 kg/m2 [11], and 34 kg/m2 [13] for the mean 
body mass index (BMI)} except one study (mean BMI 45 
kg/m2) [8], while studies showing no association between 
the A-3826G polymorphism and HDL-C [10, 12, 14] and 
carrying the G/G genotype as a protective factor for low 
HDL-cholesterolemia [15] were for relatively non-obese 
populations {i.e., mean BMI 25.5 kg/m2 (in Caucasians) 
[10], 22 kg/m2 [12], 22 kg/m2 [14], and 22-23 kg/m2 [15]}. 
Based on this background information, the present study 
aimed to compare the association between the UCP-1 gene 
A-3826G polymorphism and low HDL-cholesterolemia in 
a general Japanese population by analyzing subject-groups 
separated according to their obesity status.
Methods
This cross-sectional association study included a total of 
294 community-dwelling Japanese subjects [127 males and 
167 females, mean age 65 ± 13 (SD) years], recruited from 
community-based health check-ups conducted in the Mima 
area of Japan. The study was approved by the institutional 
ethics committee and each subject gave informed consent. 
The subjects who were basically asymptomatic and not tak-
ing any medication were eligible. Excluded were subjects 
who suffered from any acute inﬂ  ammatory disease, or had a 
clinical history of cardiovascular, thyroid, malignant, severe 
hepatic or renal diseases.
Smoking habits were determined as a current or non-
smoker through a self-reported questionnaire. In addition to 
the BMI, calculated as the body weight (kg) divided by the 
square of the height (m), the systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) were measured in the 
seated subject’s right arm using a mercury sphygmomanom-
eter. Blood was sampled after an overnight fast. The serum 
Table 1. The Clinical Characteristics of Subjects Based on the Genotypes of the Uncoupling Protein-1 Gene A-3826G 
Polymorphism in the Non-obese and Obese Groups
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; T-chol: total cholesterol;, HDL-C: high-density 
lipoprotein cholesterol; LHDLC: low high-density lipoprotein cholesterolemia; TG: triglycerides; HbA1c: hemoglobin A1c. The data are 
expressed as the means ± standard deviation, medians (interquartile range) or subject number (%). Differences in data between the 
genotype-based groups were examined by the unpaired t-test or χ2-test within each group of non-obese and obese subjects. The TG 
values were log-transformed because of their skewed distribution in the analysis. Signiﬁ  cant level: *: P < 0.05.
Genotype
Non-obese Obese
A/A + A/G G/G P value A/A + A/G G/G P value
Subject number (n) 147 45 - 75 27 -
Age (years) 66 ± 12 66 ± 13 0.98 63 ± 14 62 ± 15 0.72
Male (n) 67 (46%) 21 (47%) 0.90 30 (40%) 9 (33%) 0.55
Current smoker (n) 23 (16%) 8 (18%) 0.73 9 (12%) 3 (11%) 0.90
BMI (kg/m2) 22.2 ± 2.0 22.3 ± 1.9 0.64 27.1 ± 1.9 27.4 ± 2.3 0.48
SBP (mmHg) 139 ± 20 135 ± 19 0.26 139 ± 21 138 ± 17 0.92
DBP (mmHg) 77 ± 10 74 ± 10 0.08 78 ± 13 80 ± 13 0.52
T-chol (mmol/L) 4.85 ± 0.87 4.94 ± 1.13 0.69 4.86 ± 0.85 4.72 ± 0.97 0.48
HDL-C (mmol/L) 1.44 ± 0.38 1.43 ± 0.38 0.94 1.39 ± 0.36 1.20 ± 0.30 0.01*
LHDLC (n) 22 (15%) 6 (13%) 0.79 9 (13%) 10 (37%) < 0.01*
TG (mmol/L) 0.98 (0.75-1.23) 0.98 (0.76-1.52) 0.24 1.05 (0.84-1.51) 1.15 (0.86-1.39) 0.86
HbA1c (%) 5.6 ± 1.3 5.6 ± 1.3 0.97 5.6 ± 0.7 5.5 ± 0.6 0.85
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total cholesterol (T-chol), triglycerides (TG) and HDL-C 
levels were enzymatically measured.  Hemoglobin A1c 
(HbA1c) levels were measured using a high performance liq-
uid chromatography method. Genomic DNA was extracted 
from the subject’s buccal mucosa cells obtained using cyto-
brushes, and genotypes were determined by an intercalater-
mediated ﬂ  uorescent allele-speciﬁ  c PCR method using spe-
ciﬁ  c primers, as described previously [8].
The data were presented as the means ± standard de-
viation (SD) or the medians plus interquartile range. The 
genotype and allele frequencies for Hardy-Weinberg equilib-
rium were examined using the χ2-test. Differences between 
the genotype-based groups were compared using either the 
unpaired t-test, one way ANOVA (with a multi-comparison 
test), or χ2-test (with a residual analysis) in each group of 
non-obese and obese subjects. When the two groups by geno-
type were compared, we divided subjects into the A/A + A/G 
genotype group and the G/G genotype group according to 
the earlier study [15]. The TG values were log-transformed 
because of their skewed distribution in this analysis. A mul-
tivariate logistic regression analysis on the presence of low 
HDL-cholesterolemia, adjusted for all the measured factors 
including the G/G genotype (reference: the A/A + A/G geno-
type), was performed to observe whether the genotype was 
associated with low HDL-cholesterolemia in each group of 
non-obese and obese subjects. Obesity was deﬁ  ned as a BMI 
≥ 25 kg/m2 according to the clinical guideline of the Japan 
society for the study of obesity [16], and low HDL-choles-
terolemia was deﬁ  ned as HDL-C < 1.04 mmol/L according 
to the clinical guideline of the Japan Atherosclerosis Society 
[17]. A P-value < 0.05 was considered to be signiﬁ  cant.
Results
Overall, the distributed number of A/A, A/G and G/G geno-
types was 91 (31%), 131 (45%) and 72 (24%), respectively, 
among all subjects (n = 294). The frequency of the G-allele 
was 47%. This frequency was similar to earlier Japanese re-
ports [12, 14, 15]. These frequencies were in Hardy-Wein-
berg equilibrium (χ2 = 1.64, P = 0.45).  In the non-obese 
group (n = 192), the subject number of A/A, A/G and G/G 
genotypes was 59 (31%), 88 (46%) and 45 (23%), while in 
the obese group (n = 102), the subject number of A/A, A/G 
and G/G genotypes was 32 (31%), 43 (42%) and 27 (27%), 
respectively. There was no signiﬁ  cant difference in the geno-
type distribution between the non-obese and obese groups 
(P = 0.79).
When the clinical characteristics of subjects were 
compared between the respective genotype carriers, 
signiﬁ   cant differences in HDL-C levels (A/A genotype: 
1.37 ± 0.41 mmol/L, A/G: 1.42 ± 0.31 mmol/L, G/G: 1.20 ± 
0.30 mmol/L; F = 3.54, P = 0.03) and the prevalence of low 
HDL-cholesterolemia (A/A genotype: 5 subjects, 16%, A/G: 
Table 2. The Results of the Multivariate-adjusted Logistic Regression Analysis of Factors Associated With Low High-
density Lipoprotein Cholesterolemia in the Non-obese and Obese Groups
OR: odds ratio; CI: conﬁ  dence interval; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; T-
chol: total cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; HbA1c: hemoglobin A1c. All the listed factors, 
including the G/G genotype of the uncoupling protein-1 gene A-3826G polymorphism (reference: the A/A + A/G genotypes), were 
entered into the multivariate-adjusted logistic regression analysis models. Signiﬁ  cant level: *: P < 0.05.
Factor
Non-obese Obese
OR (95% CI) P value OR (95% CI) P value
Age (years) 1.04 (0.98-1.09) 0.19 1.04 (0.98-1.11) 0.22
Gender (male) 3.05 (0.86-10.78) 0.08 0.95 (0.19-4.75) 0.95
Current smoking (presence) 1.72 (0.43-6.83) 0.44 6.51 (0.71-59.9) 0.10
BMI (kg/m2) 0.94 (0.70-1.27) 0.69 1.53 (1.05-2.21) 0.03*
SBP (mmHg) 0.98 (0.94-1.02) 0.32 0.94 (0.89-0.99) 0.03*
DBP (mmHg) 1.02 (0.94-1.10) 0.63 1.06 (0.98-1.16) 0.15
T-chol (mmol/L) 0.95 (0.93-0.97) < 0.01* 0.95 (0.92-0.99) < 0.01*
TG (mmol/L) 1.03 (1.02-1.05) < 0.01* 1.02 (1.01-1.03) < 0.01*
HbA1c (%) 1.14 (0.79-1.65) 0.49 1.67 (0.51-5.46) 0.40
G/G genotype (presence) 0.51 (0.13-1.96) 0.33 6.85 (1.65-28.49) < 0.01*
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4 subjects, 9%, G/G: 10 subjects, 37%; F = 0.461, P = 0.01) 
were observed in the obese group. There were signiﬁ  cant 
differences in HDL-C levels between the A/G genotype 
and G/G genotype carriers (P = 0.03) and the prevalence of 
low HDL-cholesterolemia between the A/G genotype and 
G/G genotype carriers (P = 0.01) in this group. The other 
measured factors did not show any signiﬁ  cant differences 
between the respective genotype carriers in the non-obese 
and obese groups (data not shown).
The clinical characteristics of the two groups by geno-
type (the A/A + A/G genotype group versus the G/G geno-
type group) are listed in each group of non-obese and obese 
subjects in Table 1. In the obese group, the G/G genotype 
carriers had signiﬁ  cantly lower HDL-C levels and a signiﬁ  -
cantly higher prevalence of low HDL-cholesterolemia than 
the A/A + A/G genotype carriers. The other measured fac-
tors did not show any signiﬁ  cant differences between the 
two groups by genotype in the non-obese and obese groups.
Subsequently, the results of the multivariate-adjusted 
logistic regression analysis of the presence of low HDL-
cholesterolemia are shown in Table 2. In the obese group, 
the analysis revealed that carrying the G/G genotype, as well 
as the BMI and TG, was an independent and signiﬁ  cant posi-
tive factor associated with low HDL-cholesterolemia, while 
the SBP and T-chol showed an independent and signiﬁ  cant 
inverse association with low HDL-cholesterolemia. In the 
non-obese group, the same analysis revealed that the TG 
showed an independent and signiﬁ  cant positive association 
and the T-chol showed an independent and signiﬁ  cant in-
verse association with low HDL-cholesterolemia, while car-
rying the G/G genotype exhibited a non-signiﬁ  cant but re-
duced (by one-half) odds ratio (OR) for the association with 
the presence of low HDL-cholesterolemia.
Discussion
  
The present study showed that the G/G genotype of the 
UCP-1 gene A-3826G polymorphism was an independent 
and signiﬁ   cant factor positively associated with low 
HDL-cholesterolemia in the obese group, while the G/G 
genotype was a relatively protective factor associated 
with low HDL-cholesterolemia in the non-obese group. 
Even though the results of the OR for the G/G genotype 
on low HDL-cholesterolemia in the non-obese group did 
not reach a statistically signiﬁ  cant level, the impact of the 
reduction of the OR (by one-half) with regard to low HDL-
cholesterolemia should not be ignored. The results of the 
obese group are similar with the previous studies [9, 11, 
13], and the results of the non-obese group likely conﬁ  rm 
the earlier study [15]. Blood levels of HDL-C are a major 
atherosclerotic risk marker, and the association between 
HDL-C metabolism and genetic factors remains to be 
explored. It is therefore important to note that there may 
be an opposite trend for the association between the UCP-1 
gene A-3826G polymorphism and low HDL-cholesterolemia 
based on the obesity status of subjects. This may provide a 
possible explanation for the inconsistent data shown for this 
association in the previous studies [8-15] and it may also 
provide further understanding of the different roles of the 
UCP-1 gene A-3826G polymorphism under obese and non-
obese conditions.
The precise mechanisms underlying the present ﬁ  ndings 
are unclear. UCP-1 is a mitochondrial protein, potentially 
associated with energy homeostasis [3, 4]. UCP-1 is basi-
cally expressed in brown adipose tissue, and recent studies 
have shown that adult humans possess metabolically active 
brown adipose tissue [18-20]. Changes in the oxidation of 
free fatty acids in the mitochondria can alter the blood lev-
els of lipids through tissue cholesterol transport; thus, this 
pathway to control blood lipids may be affected by genetic 
polymorphisms such as the UCP-1 gene A-3826G polymor-
phism [13]. The UCP-1 expression is regulated by the extent 
of obesity, and the G allele has been reported to be relat-
ed to a reduction of the expression of the gene in an obese 
population [9]. This may be one reason for the present ﬁ  nd-
ing that the G/G genotype is positively associated with low 
HDL-cholesterolemia in obese subjects. On the other hand, 
the UCP-1 expression remains to be incompletely examined 
in non-obese populations including lean subjects [9]. There 
may be a difference in the UCP-1 expression and the role of 
the A-3826G polymorphism in regulating the levels of blood 
lipids between obese and non-obese subject-populations. 
Such a difference may partially account for the present study 
ﬁ  ndings.
In the present study, the TG (in the non-obese and obese 
groups) and BMI (in the obese group) were factors that were 
positively associated with low HDL-cholesterolemia.  These 
associations have been well-recognized [21]. In addition, 
that the T-chol (in the non-obese and obese groups) was a 
factor inversely associated with low HDL-cholesterolemia 
is plausible, because HDL-C participates in regulating the 
T-chol levels. Although the SBP (in the obese group) was 
a factor that was inversely associated with low HDL-cho-
lesterolemia, this appeared to be paradoxical, because low 
HDL-cholesterolemia is an atherosclerotic risk factor. The 
reason for this relationship was not determined, so further 
studies, including the SBP-related confounders, will be re-
quired.
The present study had a few limitations. The sample size 
was relatively small, and there was not a very high preva-
lence of low HDL-cholesterolemia. This might have lead 
to the non-signiﬁ  cance of the association between the G/G 
genotype and low-HDL-cholesterolemia in the non-obese 
group. The cross-sectional design of the study did not fully 
allow for determination of the cause-and-effect relationship 
between factors. Moreover, although there have been some 
reports showing the association between HDL-C levels and 
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genetic variations of the other types of uncoupling proteins 
such as UCP-2 and UCP-3 [22, 23], no data on such types of 
uncoupling proteins were available in this study. Additional 
studies with larger populations, prospective designs and var-
ious genetic polymorphisms are needed.
In summary, carrying the G/G genotype of the UCP-1 
gene A-3826G polymorphism was an independent and sig-
niﬁ  cant factor positively associated with low HDL-choles-
terolemia in obese subjects, and in contrast, carrying the G/G 
genotype was a relatively protective factor associated with 
low HDL-cholesterolemia in non-obese subjects. The pres-
ent ﬁ  ndings may provide an explanation for the inconsistent 
data obtained in the previous studies (of populations with a 
different status of obesity) regarding the association between 
the UCP-1 gene A-3826G polymorphism and HDL-C, and 
may provide a hint about the different roles of the UCP-1 
gene A-3826G polymorphism under obese and non-obese 
conditions. Further studies are warranted to conﬁ  rm these re-
sults and to clarify the biological mechanism(s) responsible 
for the observed association.
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